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Abstract The concentration of neuroendocrine terminals in the
neurohypophysis facilitates the identification and localization of
Ca2+ channel subtypes near neuroendocrine release sites.
Immunoblots of rat neurohypophysial tissue identified the
K11.3, K12.1, K12.2, and K12.3 Ca2+ channel subunits. Immuno-
fluorescence staining of axon terminal plasma membranes was
weak, suggesting that Ca2+ channels are dispersed. This
contrasts with the highly punctate K12.2 immunoreactivity in
bovine chromaffin cells; the neurohypophysial terminals may
therefore lack the specialized release zones found in those cells.
Immunofluorescence and immunogold labeling identify dense
core granule-like structures in the terminal cytoplasm containing
multiple Ca2+ channel types. Ca2+ channels in internal
membranes may play an important role in channel targeting
and distribution in neuroendocrine cells. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
The axons of the magnocellular neurosecretory cells of the
hypothalamus (MNCs) terminate in thousands of swellings
and endings in the neurohypophysis. These terminals, which
may be extraordinarily large (up to 15 Wm), release either
vasopressin or oxytocin in response to action potentials gen-
erated in their cell somata [1]. The extent of release is ¢nely
controlled by the rate and pattern of ¢ring [2], and this con-
trol may be mediated in part by the biophysical properties of
Ca2 channels in the terminals. Patch-clamp experiments in
isolated axon terminals have identi¢ed N-, L-, P/Q-, and R-
type Ca2 channels [3^6], although not the T-type currents
found in MNC somata [7]. Reverse transcription-polymerase
chain reaction (RT-PCR) ampli¢cation of Ca2 channel genes
in single MNC somata con¢rmed the expression of the K11.2,
K11.3, K12.1, and K12.2, but not K12.3 subunits [8] (previously
referred to as K1C, K1D, K1A, K1B, and K1E ; for a description of
the new nomenclature see [9]). The functional signi¢cance of
multiple Ca2 channel subtypes in the terminals is not well
understood. The N-type channel blocker g-conotoxin blocks
some but not all electrically stimulated release from isolated
neurohypophyses (50^70% [10,11]). Release evoked by long-
lasting depolarization with high K may be mediated by in-
£ux through any of the Ca2 channel types identi¢ed in the
terminals, except that the P/Q-type and R-type channels ap-
pear to be selectively involved in vasopressin [5] and oxytocin
release [6], respectively.
We present here an immunological study of the Ca2 chan-
nel K1 subunits in the neurohypophysial terminals. This study
aims ¢rst to determine the types of K1 subunits present, and
second to study their distribution on the terminal membrane.
Speci¢cally, we test the recent conclusion, based on rapid
measurements of voltage-gated Ca2 in£ux, that Ca2 chan-
nels are homogeneously distributed on the terminal mem-
branes [12]. These results were in contrast to those from sim-
ilar experiments on bovine chroma⁄n cells (BCCs) suggesting
that Ca2 channels are highly clustered [13] and that these
sites of in£ux correspond to specialized release zones [14].
Ca2 channel clustering on the BCC plasma membrane was
further supported by the pattern of binding of antibodies
directed against N-type channels [15]. It was therefore of in-
terest to see whether immunocytochemical experiments would
support a di¡erent distribution of Ca2 channels in these two
neuroendocrine cell types. The third aim is to study the dis-
tribution of Ca2 channels on intracellular membranes. The
presence of Ca2 channels in intracellular membranes could
be involved in transport of channels to the terminal mem-
branes from their site of synthesis in the MNC somata and
could also be involved in a regulated process of channel in-
sertion in response to a physiological signal, as has been dem-
onstrated in Aplysia neurons [16,17] and in sea urchin eggs
[18].
2. Materials and methods
2.1. Isolation of neurohypophysial terminals
The axon terminals of the neurohypophysis were isolated as previ-
ously described [4], with minor modi¢cations as described below. An-
imal use was reviewed and approved by the Mayo Foundation Institu-
tional Animal Care and Use Committee. Male Long^Evans rats (150^
300 g) were killed by decapitation using a small rodent guillotine
(model 51330; Stoelting Company, Wood Dale, IL, USA) following
anesthesia with chloroform. The neurohypophysis was extracted and
incubated for 90 min at 34‡C in 10 ml of an oxygenated (100% O2)
saline containing (in mM): NaCl, 120; KCl, 5; MgCl2, 1; CaCl2, 1;
piperazine-N,NP-bis[2-ethanesulfonic acid] disodium salt (PIPES), 20;
D-glucose, 25; pH of 7.1; and containing trypsin (0.7 mg/ml; Sigma
type XI, Sigma, St. Louis, MO, USA). The neurohypophysis was then
rinsed in trypsin-free oxygenated PIPES saline (up to 2 h), triturated
with ¢re-polished pipettes (0.2^0.5 mm in diameter), and plated onto
untreated glass-bottomed Petri dishes. Experiments were performed
on terminals isolated using a trypsin incubation to maintain condi-
tions used for previous electrophysiological experiments [4,12]. Similar
immunocytochemical results were obtained when terminals were iso-
lated by trituration in the absence of trypsin (data not shown).
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2.2. Preparation and culture of BCCs
Chroma⁄n cells were isolated from bovine adrenal medullae by
enzymatic digestion [15]. Isolated cells were suspended in Dulbecco’s
modi¢ed Eagle’s medium supplemented with 25 mM HEPES, 10%
fetal calf serum, 8 mM 5-£uoro-2P-deoxyuridine, 50 mg/ml gentami-
cin, 10 mM cytosine arabinofuranoside, 2.5 mg/ml fungizone, 25 U/ml
penicillin, 25 mg/ml streptomycin and plated at a density of 100 000^
300 000 cells/ml on glass coverslips that formed the bottom of a 35
mm diameter Petri dish. Cells were cultured in a humidi¢ed atmos-
phere with 5% CO2 at 37‡C for 1^3 days prior to use.
2.3. Western blots
One to three neurohypophyses were rapidly dissected and homog-
enized on ice using a disposable tissue grinder (Kontes Glass) in a
PIPES bu¡er (pH 7.4) containing the following mixture of protease
inhibitors: pepstatin A, leupeptin, and aprotinin (each at 1 mg/ml),
phenylmethylsulfonyl £uoride (0.2 mM), benzamidine (0.1 mg/ml),
and calpain inhibitors I and II (8 mg/ml each). One ¢fth volume of
5ULaemmli bu¡er containing 1% L-mercaptoethanol was added to
the sample, which was then heated at 70‡C for 10 min, centrifuged,
and run on a 6% SDS^PAGE gel (approximately 0.25^0.50 neuro-
hypophysis per lane). The proteins were then transferred to nitrocel-
lulose membranes (Hybond-ECL, Amersham, Little Chalfont, Bucks,
UK). Strips were incubated with a⁄nity-puri¢ed rabbit polyclonal
antibodies (Alomone Labs, Jerusalem, Israel) directed against por-
tions of the K11.3, K12.1, K12.2, and K12.3 Ca2 channel subunits
from rat (1:500 dilutions) for either 1 h at room temperature or over-
night at 4‡C. Phosphate-bu¡ered saline, pH 7.2 (PBS; Gibco BRL,
Gaithersburg, MD, USA) and 0.1% Tween 20 were used in all the
blocking, incubation and washing steps. Non-fat milk was present in
the blocking (5%) and in the washing solutions (1%). Anti-rabbit or
anti-rat horseradish peroxidase-linked antibodies were used at 1/1000
dilutions as the secondary antibodies. The immunoreactive bands
were visualized using ECL Western blotting detection reagents (Amer-
sham Pharmacia). To demonstrate the speci¢city of the antibodies, the
membranes were stripped of antibodies by incubating with stripping
bu¡er (62.5 mM Tris, pH 6.8, 100 mM L-mercaptoethanol, and 2%
SDS) at 50‡C for 30 min, washed twice for 15 min in washing solu-
tion, and then exposed as above to antibodies pre-incubated for 1 h
with an equal weight of the antigen peptides (Alomone Labs).
2.4. Immuno£uorescence
Acutely isolated neurohypophysial terminals (1^3 h following plat-
ing) or BCCs (1^3 days following plating) were rinsed twice in PBS,
and then ¢xed for 20 min in ‘PLP’ ¢xative (PBS with 4% paraform-
aldehyde, 0.05% sodium periodate, and 0.34% lysine [19]). Following
eight rinses in PBS, the dishes were incubated 30 min in blocking
solution (PBS with 4% normal goat serum, and 0.02% Triton X-
100), and then left overnight at 4‡C in blocking solution containing
the indicated antibodies. These included an a⁄nity-puri¢ed rabbit
polyclonal antibody directed against rat syntaxin 1 A/B (1:100; Alo-
mone Labs), mouse ascitic £uid containing a monoclonal antibody
directed against syntaxin 1 (1:20; Sigma), a rat monoclonal antibody
directed against the K12.2 Ca2 channel subunit (cc20, 1:500 [15]) and
a⁄nity-puri¢ed rabbit polyclonal antibodies directed against the
K11.3, K12.1, K12.2, and K12.3 Ca2 channel subunits from rat (Alo-
mone Labs; 1:100, 1:200, 1:200; and 1:1000, respectively). Following
eight rinses in blocking solution, the dishes were incubated for 30 min
in the dark with either an anti-rabbit (or anti-rat) secondary antibody
from sheep (conjugated with Cy2 or Cy3, diluted 1:100; Amersham)
or a biotinylated anti-rabbit antibody followed by a 30 min incuba-
tion in streptavidin labeled with Cy2 or Cy3 (1:1000; Amersham).
The dishes were then rinsed (four times in blocking solution, four
times in PBS), ¢lled with mounting solution (0.1% p-phenylenedi-
amine in PBS/glycerol; 1:3), topped with a coverslip, and maintained
at 4‡C until viewing. For double labeling experiments with two di¡er-
ent Ca2 channels, the ¢xation and labeling procedure was repeated
with a di¡erent primary antibody and a secondary antibody labeled
with a di¡erent £uorophore prior to mounting. Control experiments
showed that the second ¢xation e¡ectively prevented binding of the
second secondary antibody to the ¢rst primary antibody (see Fig. 5B).
Samples were viewed on a Zeiss Axiovert microscope using a mercury
lamp and a cooled CCD camera (Photometrics, Tucson, AZ, USA),
or for the double labeling experiments, a confocal microscope (model
LSM 510, Carl Zeiss, Inc., Oberkochen, Germany). No attempt was
made to investigate whether Ca2 channel types are di¡erentially dis-
tributed on vasopressin and oxytocin terminals, which has been pro-
posed based on di¡erences in sensitivity to antagonists [5,6].
2.5. Immunoelectron microscopy
Neurohypophyses were dissected, ¢xed in 4% paraformaldehyde
and 0.2% glutaraldehyde for 2 h, rinsed in PBS, and dehydrated by
incubation with a series of ethanol solutions at progressively lower
temperature ending with 80% ethanol at 320‡C. The tissue was in¢l-
trated with LR White resin for 24 h, embedded in fresh LR White and
polymerized for 2^3 days at 50‡C. Thin sections (V250 nm) were
mounted on nickel grids and blocked in PBS containing 0.1% Tween
20 (PBST) and 2% normal goat serum. The indicated Ca2 channel
antibodies were diluted 1:20 in PBST and grids were incubated for 3 h
at room temperature. Sections were rinsed in PBST and incubated in a
secondary antibody conjugated to colloidal gold (diameter 5 nm).
After rinsing thoroughly in PBST and water, the colloidal gold was
silver enhanced for 3^4 min (using a commercially available kit from
Amersham), stained with uranyl acetate and lead citrate, and exam-
ined using a Philips CM-10 transmission electron microscope, at
60 kV.
3. Results
3.1. Calcium channels in the neurohypophysis
PCR studies of MNC somata have demonstrated expres-
sion of the K11.2, K11.3, K12.1, and K12.2 Ca2 channel sub-
unit genes in MNC somata [8] and electrophysiological re-
cordings from isolated MNC axon terminals have provided
evidence for L-, N-, P/Q-, and R-type Ca2 currents [3^6]. To
test for the presence of di¡erent K1 subunit proteins, immu-
noblot analysis was performed on neurohypophysial homoge-
nates. The neurohypophysis is devoid of neuronal somata and
is composed almost entirely of MNC axons and axon termi-
nals [20]. Pituicytes, the glial cells found in the neurohypoph-
ysis, are unlikely to express voltage-gated Ca2 channels [21].
Antibodies generated against speci¢c sequences of the K11.3,
K12.1, K12.2, and K12.3 Ca2 channel subunits each recog-
nized speci¢c protein bands (Fig. 1). The K11.3 antibody la-
beled a protein of about 170^180 kDa. The antibody against
K12.1 recognized a band of about 170^180 kDa and a band of
about 220^240 kDa. The antibody against K12.2 labeled a
band of about 210 kDa, while the K12.3 labeled a protein
band at about 220^240 kDa and a lighter band at about
Fig. 1. Immunoblots of neurohypophysial homogenates probed with
rabbit polyclonal antibodies raised against the K11.3, K12.1, K12.2,
and K12.3 Ca2 channel subunits. The membranes to the left of
each set show the staining of the membranes with the indicated
antibodies; membranes on the right show the lack of staining when
the antibodies were pre-adsorbed with the peptide fragments of the
Ca2 channels against which they were raised. The positions of mo-
lecular weight markers run in adjacent lanes are shown for compari-
son.
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170^180 kDa. The presence of multiple isoforms of these
channel subunits in these molecular weight ranges is consis-
tent with previous immunological and molecular work [22^
33]. Pre-adsorption of the antibodies with the corresponding
Ca2 channel peptide completely prevented binding (Fig. 1).
Antibodies directed against K11.2 did not recognize a protein
band in immunoblots of neurohypophysial homogenates and
were thus not used for immunocytochemical experiments.
3.2. Immuno£uorescence
The distribution of Ca2 channel subtypes in isolated neu-
rohypophysial terminals was studied using immuno£uores-
cence. Antibodies against the K11.3, K12.1, K12.2, and K12.3
subunits yield similar patterns of immuno£uorescence staining
(Fig. 2). None of these antibodies yield clear staining of the
plasma membrane. Each does, however, show punctate stain-
ing within the terminal cytoplasm. Fig. 2 shows the labeling of
each of the antibodies at two focal planes in an isolated ter-
minal near the plane of largest cross-sectional area. In all
cases there are a large number of structures distributed
throughout the terminal cytoplasm that show some £uores-
cence and a smaller number of structures that stain much
more brightly.
The absence of detectable plasma membrane staining would
be consistent with a homogeneous distribution of Ca2 chan-
nels, if it is assumed that the density is below that detectable
by our method. A terminal isolated under these conditions
with a diameter of 15 Wm might have a peak Ca2 current
of about 200 pA in 10 mM Ca2 [12]. If it is assumed that
N-type channels in these cells have roughly half the conduc-
tance of L-type currents [34], that L-type channels have a
conductance of about 0.1 pA at 0 mV in 10 mM Ca2 [35],
and that N-type channels constitute one-half or less of the
total current [5], it can be calculated that a depolarization
would be expected to open about 2000 channels, or about
eight channels per Wm2. This corresponds to a mean inter-
channel distance, assuming that the channels are homogene-
ously distributed and that all open during a depolarization, of
about 350 nm, which might be below the sensitivity of our
method to detect.
The presence of syntaxin 1 has been demonstrated in the
neurohypophysis using immunoblotting [36], and antibodies
against syntaxin 1 were able to co-immunoprecipitate a por-
tion (V50%) of g-conotoxin GVIA binding sites in neuro-
hypophysial homogenates [37]. The distribution of syntaxin
immunoreactivity on neurohypophysial terminal membranes
may therefore re£ect in part the distribution of N-type Ca2
channels. The observed pattern of immuno£uorescence stain-
ing for an antibody against syntaxin 1 is primarily on the
plasma membrane and appears to be homogeneous (Fig.
3A). This is in marked contrast to the distribution of syntaxin
immunoreactivity in BCCs. Previous experiments with a
monoclonal antibody directed against the N-type Ca2 chan-
nel have shown that these channels are highly concentrated at
a small number of sites on the BCC plasma membrane [15].
These data are consistent with data using pulsed laser Ca2
imaging showing that in£ux of Ca2 during brief depolariza-
tions of patch-clamped BCCs occurs in a non-homogeneous
fashion [13] and that the sites on in£ux are associated with
sites of preferential release [14]. Confocal imaging experiments
show that the punctate immunoreactivity for the K12.2 Ca2
channel subunit in BCCs largely overlaps with a similar punc-
tate distribution for syntaxin (Fig. 3C). This suggests that
both K12.2 and syntaxin are speci¢cally targeted to organized
release sites on the BCC membrane. There are also spots of
syntaxin immunoreactivity that do not coincide with those of
K12.2, which may be explained by clusters of other types of
Ca2 channels that are also associated with clusters of syntax-
in. This is consistent with pharmacological experiments show-
ing that some, but not all sites of localized Ca2 in£ux are
blocked by g-conotoxin [15]. Syntaxin 1 staining has also
been shown to be localized at release sites at the frog neuro-
muscular junction [38], at presynaptic boutons in the cerebel-
lum [39], and at ribbon synapses in cochlear hair cells [40].
The lack of punctate staining for either Ca2 channels or
syntaxin 1 on the neurohypophysial terminals is consistent
with the hypothesis that these terminals lack large clusters
of Ca2 channels on their plasma membrane [12].
Fig. 2. Immuno£uorescence labeling of isolated neurohypophysial
terminals using rabbit polyclonal antibodies directed against por-
tions of the K11.3, K12.1, K12.2, and K12.3 Ca2 channel subunits.
On the left are di¡erential interference contrast (DIC) images of ¢ve
neurohypophysial terminals and on the right are £uorescence images
showing the pattern of labeling with the indicated antibodies, and
the lack of staining in the control experiment. For each of the anti-
bodies, £uorescence images are shown at two di¡erent focal planes
near the widest part of the terminal; the approximate location of
the terminal membrane is shown by the dotted line. Note the pres-
ence of punctate cytoplasmic staining for each of the antibodies. A
control experiment, for which no primary antibody was added, is
shown at the bottom.
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3.3. Electron microscopy
To determine whether Ca2 channels are associated with
speci¢c intracellular structures, we studied the immunoreac-
tivity of Ca2 channel antibodies at the electron microscopic
level. Immunogold labeling of rapidly ¢xed neurohypophysial
tissue with antibodies against K11.3, K12.1, and K12.2 subunits
revealed a pattern of staining that was similar to that seen
with immuno£uorescence (Fig. 4). Although little or no bind-
ing of the Ca2 channel antibodies to the terminal plasma
membrane was observed, intense labeling was evident in a
small number of internal structures similar in size and appear-
ance to dense core granules. The labeling of structures with
this appearance was heterogeneous; some structures were la-
beled with many gold particles whereas the majority was la-
beled with few or none. This observation supports the hypoth-
esis that a population of internal structures similar to dense
core granules is involved in the tra⁄cking of Ca2 channels
from their site of synthesis in the MNC somata to the termi-
nal membrane.
3.4. Colocalization of Ca2+ channel subtypes
Double staining with antibodies directed against K12.1 and
K12.2 shows that the immunoreactivity for the two antibodies
is partly overlapping (Fig. 5A). Terminals were ¢xed, incu-
bated with one Ca2 channel antibody and then a labeled
secondary antibody (e.g. Cy2) and then ¢xed again and incu-
bated with a second Ca2 channel antibody and a di¡erently
labeled secondary antibody (e.g. Cy3). Shown are two sets of
confocal images (separated by 0.5 Wm) that show staining for
K12.1 (red), staining for K12.2 (green), and an image showing
the combination of the two, in which areas of colocalization
appear yellow. Several bright yellow structures are visible in
the two images, indicating the presence of both Ca2 channel
subtypes. Similar results were obtained for double staining
with K12.1 and K11.3 and with K12.2 and K11.3 (not shown).
In control experiments, the procedure was repeated, but with-
out incubation with the second primary antibody. The resul-
tant image is dominated by the £uorescence of the ¢rst sec-
ondary antibody (red) and shows little binding of the second
Fig. 3. Immuno£uorescence labeling of neurohypophysial terminals and bovine chroma⁄n cells using a rabbit polyclonal antibody directed
against syntaxin 1. A: The pattern of £uorescence obtained in an isolated neurohypophysial terminal. Note the homogeneous membranous
staining. The control shows the lack of staining when the primary antibody was omitted. B: Double labeling of an isolated BCC with the anti-
syntaxin antibody (red) and a monoclonal rat antibody (cc20) directed against the N-type Ca2 channel (green) shows that both yield a punc-
tate pattern of staining. At this focal plane one intense spot on the cell membrane is visible in both cases. Overlaying the two patterns shows
colocalization of the immunoreactivity for the two antibodies (yellow). The control image shows the lack of staining in the absence of primary
antibodies. C: Double labeling with cc20 and anti-syntaxin in a ¢eld of BCCs. Note that there are several yellow spots indicating colocalization
of the immunoreactivity of the two antibodies, and also intense red spots on the membranes suggesting clusters of syntaxin in the absence of
N-type Ca2 channels. The cc20 antibody was kindly given by Dr. V.A. Lennon.
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secondary antibody (which would appear in green, Fig. 5B).
This demonstrates that the second ¢xation e¡ectively pre-
vented interaction between the ¢rst primary antibody bound
to the sample and the second secondary antibody. When the
second primary antibody was the same as the ¢rst, the £uo-
rescence from the two secondary antibodies overlapped al-
most completely. These results suggest that the membranous
structures contain more than one type of channel, and may be
involved in the tra⁄cking of Ca2 channels to the terminal
membrane.
4. Discussion
The identi¢cation of K11.3, K12.1, K12.2, and K12.3 Ca2
channel subunits in the neurohypophysial terminals is consis-
tent with pharmacological and biophysical experiments that
identi¢ed P/Q-, N-, L-, and R-type Ca2 currents [3^6]. RT-
PCR experiments on single MNC somata were able to amplify
genes for the K11.2, K11.3, K12.1, and K12.2 Ca2 channel
subunits, but were unable to ¢nd detectable expression of
the K12.3 subunit [8]. Pharmacological evidence for R-type
currents in oxytocin-releasing terminals [6], however, as well
as the evidence presented here, supports the presence of K12.3
in the neurohypophysis. The functional signi¢cance of multi-
ple Ca2 channel types in these terminals is not clear. N-type
currents are important in mediating neuropeptide release,
since g-conotoxin GVIA can block 50^70% of electrically
evoked release [10,11]. Blockers of P/Q- and R-type currents
can inhibit the K-evoked release of oxytocin [5] and vaso-
pressin [6], respectively. The role of L-type currents in evoking
release is unclear. Dihydropyridines, which block L-type cur-
rents, can inhibit K-evoked vasopressin release [10,41,42],
but have a small e¡ect if any on electrically evoked secretion
[10,11,43]. The presence of immunoreactivity for an antibody
directed against the K11.3 subunit supports the earlier immu-
nohistochemical observation of K11.3 in the supraoptic nu-
cleus of the hypothalamus [44], where many of the MNC
somata are found. The terminals may or may not express
the K11.2 subunit as well. The presence of K11.3 is consistent
with the low threshold of activation (350 mV) of L-type
currents in MNC somata [7], since these channels have similar
thresholds both in cochlear hair cells [45] and when they are
expressed in oocytes [29]. While K11.3 subunit labeling is gen-
erally not found at synaptic terminals in the CNS [30], L-type
currents constituted from the K11.3 subunit are associated
with release from pancreatic L-cells [46] and cochlear hair cells
[45].
The lack of punctate staining for Ca2 channels or for
syntaxin suggests that the terminals do not have the special-
ized release sites found in the BCCs, although this conclusion
must be viewed with caution in the absence of a clear pattern
of staining on the terminal membrane. This interpretation is
consistent with rapid measurements of voltage-gated Ca2
in£ux into these terminals [12] and has implications for the
mechanism of secretion in the terminals. Ca2 channels and
the exocytotic apparatus are closely colocalized at synaptic
terminals [47,48], which allows a close temporal relationship
between Ca2 in£ux and evoked release [49]. This relationship
allows the rapid processing of information upon which brain
function depends. Release from endocrine and neuroendo-
crine systems, however, is generally much slower [50^53] sug-
gesting that the relationship of Ca2 channels and the release
Fig. 4. Immunogold labeling of neurohypophysial terminals using
rabbit polyclonal antibodies directed against portions of the K11.3,
K12.1, and K12.2 Ca2 channel subtypes. Fixed and embedded thin
neurohypophysial sections were incubated with the indicated pri-
mary antibody followed by incubation with a secondary antibody
conjugated to 5 nm gold particles. In each case, a subset of granule-
sized membranous structures were labeled (some examples are indi-
cated by the white arrows). When the sections were treated with
non-immune serum rather than primary antibodies, there was no la-
beling with gold particles.
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apparatus is not as close. Such release is largely blocked by
the slow Ca2 chelator EGTA, which suggests that Ca2 must
di¡use from its site of entry to its site of action [54]. The slow
rate of endocrine and neuroendocrine release therefore sug-
gests that there is no direct association between channels and
releasable granules, and that release may be triggered by a
general increase in sub-membranous Ca2, caused by the sum-
mation of in£ux through widely dispersed Ca2 channels.
Thus a dispersed distribution of Ca2 channels on the neuro-
hypophysial membrane would be consistent with the relatively
slow rate of exocytotic release observed in single cells follow-
ing depolarization [49,55^58] and the fact that it is largely
blocked by the inclusion of EGTA in the patch pipette
[50,56,58]. This model is also consistent with observations
that release of neuropeptide is optimized by bursts of action
potentials interspersed between periods of quiescence [2],
which mimics patterns of electrical behavior seen in vivo [1].
Rapid measurements of voltage-gated Ca2 in£ux in BCCs,
Fig. 5. Colocalization of immuno£uorescence labeling of isolated neurohypophysial terminals using rabbit polyclonal antibodies directed against
portions of the K12.1, and K12.2 Ca2 channel subtypes. A: Two focal planes of a terminal double-labeled with antibodies directed against the
two antibodies. Terminals were ¢xed, incubated with an antibody directed against K12.1 and then a Cy3-conjugated secondary antibody. They
were then ¢xed again, incubated with an antibody directed against K12.2, and then a Cy2-conjugated secondary antibody. Labeling with K12.1
is shown in red, and labeling with K12.2 is shown in green. The overlay shows that there is a small number of cytoplasmic structures intensely
labeled by both antibodies. B: In a control experiment a similar procedure was followed except that the second primary antibody was omitted
(i.e. the antibody directed against K12.2 was not added). The absence of £uorescence from Cy2 indicates that the second ¢xation e¡ectively pre-
vents binding of the second secondary antibody to the ¢rst primary.
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in contrast, suggest that Ca2 channels in these neuroendo-
crine cells are highly clustered [13]. By combining pulsed laser
Ca2 imaging and amperometric measurement of catechol-
amine release it was shown that these Ca2 channel clusters
represent organized release sites [14]. Immunocytochemical
analysis supports the clustering of N-type channels on the
chroma⁄n cell membrane [15] and suggests that channel clus-
ters are associated with clusters of syntaxin 1 (Fig. 3). Zones
of preferential release are supported with independent data on
amperometric localization of release sites [59], and on the
localization of fusion of visualized granules [60]. Organized
release sites may mediate the rapid phase of catecholamine
release seen in response to brief depolarizations of chroma⁄n
cells, including single action potentials [61,62]. Ca2 channel
clustering in the BCCs may therefore represent a specializa-
tion for rapid release that is not present in neurohypophysial
terminals.
The sequestration of voltage-gated Ca2 channels in inter-
nal membranes has been observed in neuroendocrine cells in
Aplysia californica [17]. In these cells, two types of Ca2 chan-
nels were found to have a di¡erent subcellular distribution ^
one type of channel was found primarily on internal mem-
branes, while a second channel type was found primarily on
the plasma membrane. The translocation of the channel found
in the internal membranes to the plasma membrane may
underlie the appearance of a new species of channel on the
cell surface that occurs in response to treatment with protein
kinase C activators [16] and that results in an enhancement of
Ca2 in£ux during the episodic release of egg-laying hormone
from these cells [63]. Internal storage of N-type Ca2 channels
has been demonstrated in neuroblastoma and PC12 cell lines
[64,65]. Channels were found to be enriched in cellular frac-
tions containing chromogranin B-containing secretory gran-
ules and were translocated to the plasma membrane by expo-
sure to various secretagogues [65]. Regulated mobilization of
channels from internal stores has also been demonstrated in
the mammalian collecting duct and the amphibian bladder
where water channels are inserted in response to vasopressin
[66]. The internal stores of Ca2 channels in the neurohypo-
physial membranes may therefore serve as a reserve pool that
could be inserted into the plasma membrane to enhance the
release of neuropeptides when the physiological need is high.
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